MENU
+Compare
MBRX
Stock ticker: NASDAQ
AS OF
Apr 3 closing price
Price
$0.87
Change
-$0.09 (-9.38%)
Capitalization
11.56M

MBRX Moleculin Biotech Forecast, Technical & Fundamental Analysis

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses... Show more

MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MBRX with price predictions
Apr 02, 2025

MBRX in -7.78% downward trend, declining for three consecutive days on April 01, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MBRX declined for three days, in of 354 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MBRX as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MBRX turned negative on March 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

The Aroon Indicator for MBRX entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MBRX advanced for three days, in of 199 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.138) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MBRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MBRX is expected to report earnings to fall 44.62% to -277 cents per share on May 09

Moleculin Biotech MBRX Stock Earnings Reports
Q1'24
Est.
$-2.78
Q4'23
Missed
by $1.79
Q3'23
Beat
by $0.03
Q2'23
Beat
by $0.07
Q1'23
Beat
by $0.01
The last earnings report on March 22 showed earnings per share of -501 cents, missing the estimate of -323 cents. With 336.88K shares outstanding, the current market capitalization sits at 11.56M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
5300 Memorial Drive
Phone
+1 713 300-5160
Employees
18
Web
https://www.moleculin.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZYME11.92N/A
N/A
Zymeworks
VRSN255.43-0.07
-0.03%
VeriSign
USEA1.32-0.01
-0.75%
United Maritime Corp
INFU5.03-0.29
-5.45%
InfuSystem Holdings
HIMS27.99-3.23
-10.35%
Hims & Hers Health

MBRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MBRX has been loosely correlated with EDSA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MBRX jumps, then EDSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBRX
1D Price
Change %
MBRX100%
-9.60%
EDSA - MBRX
36%
Loosely correlated
-5.31%
AMRN - MBRX
32%
Poorly correlated
-1.85%
DOMH - MBRX
30%
Poorly correlated
-10.71%
AXON - MBRX
29%
Poorly correlated
-3.35%
VKTX - MBRX
29%
Poorly correlated
-5.69%
More